Skip to main content
. 2018 Oct 2;7:51–57. doi: 10.1016/j.phro.2018.09.003

Fig. 4.

Fig. 4

FACBC uptake against prostate specific antigen (PSA) (A), pathological tumour stage (pT) (B) and Gleason score (C). The metabolic phase (upper panel) and the initial perfusion phase (bottom panel) of dynamic FACBC PET.